Inside the FDA's New Office in China
Product Details
Who works in the office? What are the staff’s responsibilities? How are they organized? Are they finding and correcting violations? Is it now more expensive to contract with Chinese companies? Is the FDA slowing down imports?
Get the answers to these and many more questions …
In this 90-minute Encore presentation, Raymond Bonner of Sidley Austion, will give you the benefit of his interactions with the FDA staff in Beijing as he explains what they do, what they inspect and what they are finding. In addition, he’ll explain what it means now to outsource to, or import from, China. Sidley Austin is the first international law firm to establish a stand-alone, comprehensive food and drug regulatory practice in China.
If you ever wanted a first-hand account of what’s happening in China, you must register now for this exciting webinar. Sign up your entire team to listen in and discover:
- The mission and organizational structure of the FDA’s China office — including who, what, where, when and how the office operates
- What the responsibilities of the staff are (inspecting facilities or products ready for export?)
- Analysis of the regulatory actions and sanctions they have taken or violations they have found to date
- Drug and device firms’ experiences with the new system
- Whether the FDA’s actions are making outsourcing to China less cost-effective
Stop wondering what the FDA’s China office is doing and find out from an expert who knows. Register now and you'll get an opportunity to ask your toughest questions during the Q&A session.